(r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4]oxazepine → (r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4] oxazepine hydrochloride
Reaction equation
[ClH:1].O1CCOCC1.[CH3:8][O:9][C:10]1[CH:39]=[CH:38][C:13]([CH2:14][CH2:15][N:16]2[CH2:21][CH2:20][CH2:19][CH2:18][C@@H:17]2[CH2:22][N:23]2[C:29]3[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=3[CH2:27][O:26][C:25]3[CH:34]=[CH:35][CH:36]=[CH:37][C:24]2=3)=[CH:12][CH:11]=1>ClCCl>[ClH:1].[CH3:8][O:9][C:10]1[CH:11]=[CH:12][C:13]([CH2:14][CH2:15][N:16]2[CH2:21][CH2:20][CH2:19][CH2:18][C@@H:17]2[CH2:22][N:23]2[C:29]3[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=3[CH2:27][O:26][C:25]3[CH:34]=[CH:35][CH:36]=[CH:37][C:24]2=3)=[CH:38][CH:39]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
3.0 ml of 4 M hydrochloric acid/dioxane was added to a solution of (R)-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4]oxazepine (0.63 g) in dichloromethane (10 ml), and they were stirred for 2 hours. The solvent was evaporated under reduced pressure. The obtained residue was recrystallized from a mixed solvent of acetone and ether to obtain the title compound in the form of a white solid (496 mg, 73%).
Workup
- customThe solvent was evaporated under reduced pressure
- customThe obtained residue was recrystallized from a mixed solvent of acetone and ether
Sources & evidence
- ORD record
- ord-a1c5a4c9a3bd412c829a6b137d83a879
- Source dataset
- uspto-grants-2003_03
- Patent number
- US06528504B2
Reaction notes
Loading…